zoledronate (AXS-02) / Axsome Therap - LARVOL DELTA

COAST-1: A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions (clinicaltrials.gov) - P3; N=346; Active, not recruiting; Sponsor: Axsome Therapeutics, Inc.; Recruiting ➔ Active, not recruiting; Trial completion date: Sep 2017 ➔ Dec 2020; Trial primary completion date: Sep 2017 ➔ Dec 2020

Clinical • Enrollment closed • Trial completion date • Trial primary completion date